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The purpose of this study was to develop poly(amidoamine) (PAMAM)-functionalized
multi-walled carbon nanotubes (MWNTs) loaded with a poorly water-soluble drug, inten-
ded to improve the drug-loading capacity, dissolution and design a sustained release
system. MWNTs were modified with a carboxyl group by acid treatment and then complex
with PAMAM. PAMAM-MWNTs were investigated as a scaffold for loading the model drug,
Carvedilol (CAR), using three different methods (the fusion method, the incipient wetness
impregnation method, and the solvent method). The effects of different pore size, specific
surface area and physical state were systematically studied using FT-IR, TGA, SEM, DSC,
nitrogen adsorption, XPS and XRD. All the samples made by PAMAM-MWNTs to load the
drug had a marked effect on the drug-loading capacity as well as drug dissolution, espe-
cially the Ⅱ-30%.
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attention is being paid on recently.
There has been intense interest in CNTs since their dis-
covery by Iijima in 1991 because of their excellentmechanical,
electrical and nonlinear optical properties [4]. CNTs, in both
single-walled andmulti-walled (SWNT andMWNT) forms, are
widely considered to be the “wonder materials” of the 21st
century and offer new paradigms in a variety of fields,
including electronics, structural integrity, biomedical engi-
neering, tissue engineering, drug delivery technology, nano-
injection systems, neuroengineering, gene therapy, and
biosensor technology [5e10]. They are cylindrical molecules
consisting of a hexagonal arrangement of sp2-hybridized
carbon atoms. An example of the usefulness of CNTs in
biomedicine is their relatively large length-to-diameter ratio
with a very large surface area, which makes them suitable for
high-sensitivity molecular detection and recognition.
The insolubility of CNTs in aqueous media has been a
major technical barrier. Modification through chemical func-
tionalization using suitable dispersants and surfactants can
enhance their solubility and is essential for their controlled
dispersion [11e14]. For example, adding polar molecules can
render CNTs soluble, whereas nonpolar moieties make CNTs
immiscible. Such processes have proved especially important
in that insoluble CNTs have been found to cause cell death in
culture [15e17].
The first complete dendrimer family which has been
synthesized, characterized and commercialized is repre-
sented by poly(amidoamine) (PAMAM) dendrimers. They
have been shown to be safe and non-immunogenic and they
are used in drug delivery, delivery of antisense nucleotides
and gene therapy, both in vitro and in vivo [18]. PAMAM
could increase the solubility of the water-insoluble drug [19].
Cheng et al. [20] investigated the effect PAMAM to increase
the solubility of ketoprofen, brufen, diflonid and naproxen.
The result suggested that PAMAM could increase the solu-
bility of the naproxen well. Bharathi Devarakonda et al. [21]
certified that PAMAM could increase the solubility of
nifedipin.
With respect to PAMAM could increase the drug-loading
because of the large internal cavity area and also could
improve the solubility of the poorly soluble drugs. As a car-
rier, the MWNTs have a larger surface area, which can make
the drugs disperse well. It can be expected that MWNTs
modified by PAMAM might have a higher drug-loading and
might improve the solubility of the insoluble drugs better.
Furthermore, consist of the crosslink structure of PAMAM-
functionalized MWNTs, it may change the drug release rate
and obtain an oral sustained drug delivery system for poorly
water-soluble drugs. In this paper, we used the acid to cover
the MWNTs by attaching carboxylic groups to their ends and
at the defect points [22], then attached PAMAM. Carvedilol
(CAR), 1-[carbazole-(4)-oxy]-3-[(2-methoxy-phenoxy-ethyl)-
amino]-2-propanol, is a vasodilator/b-adrenoceptor antago-
nist used for the treatment of hypertension. CAR has been
shown to exhibit multiple beneficial functions, such as
neuroprotection and myocardial and endothelial protection
[23]. To study the drug-loading mechanism, data on the pore
size, surface area, and physical state of the drug were ob-
tained by nitrogen adsorption, XRD, DSC and XPS.2. Materials and methods
2.1. Materials
MWNTs were purchased from Chengdu Organic Chemicals
Co. Ltd., Chinese Academy of Sciences (Chengdu, China).
Concentrated nitric acid (65%), ethylenediamine (EDA),methyl
acrylate and concentrated sulfuric acid (98%) were purchased
from YuWang (Shenyang, China). All other chemicals were of
reagent grade and were used as purchased without further
purification. Deionized water was prepared by ion exchange.
2.2. Preparation of PAMAM
Ethylenediamine (EDA) core PAMAM dendrimers were syn-
thesized using the divergent growth approach of Tomalia [24].
The synthesis involves two consecutive chain forming re-
actions, the exhaustive Michael addition reaction, and the
exhaustive amidation reaction, carriedout repeatedly.Michael
addition of methyl acrylate to ethylenediamine in methanol
solutiongives theester terminatedhalf generationdendrimers
designated (G0.5, G1.5, G2.5). The exhaustive amidation reac-
tion of esterterminated dendrimers with a large excess of
ethylenediamine inmethanol produces amine terminated full
generation dendrimers referred to as G1.0, G2.0 and G3.0.
Repetition of the Michael addition and amidation reactions
produces the next and higher generation dendrimers.
2.3. Preparation of COOH-MWNTs
Cutting and purification of the MWNTs was carried out as
described in the literature [25]. The MWNTs (500 mg) were
added to a mixture of 98% H2SO4 and 65% HNO3 (V: V ¼ 3:1,
200 mL) and agitated for 12 h at room temperature. The cut
MWNTs were thoroughly washed with ultrapure water and
dispersed in HCl and refluxed for 24 h then collected by
filtration and washed with ultrapure water. The product was
then dried at 40 C for 24 h.
2.4. Preparation of PAMAM-MWNTs
A dimethyl sulfoxide (DMSO) suspension (50 ml) of 0.1
mg/ml carboxylated MWNTs containing 100 mg 1,3-
dicyclohexylcarbodiimide (DCC) was slowly added to a
DMSO solution (1.5 ml) of 20% PAMAM G3.0 under high-speed
agitation. PAMAM-MWNTs were obtained by purifying with
dialysis (molecular weight cutoff, 30,000) using pure water to
remove the excess PAMAM and auxiliary reagents.
2.5. Drug-loading procedures for PAMAM-MWNTs
Three different methods were used to load PAMAM-MWNTs
with CAR.
2.5.1. The fusion method (Ⅰ)
Physical mixtures of CAR and PAMAM-MWNTs with different
weight proportions were prepared and heated above the
melting point of the drug at 130 C for 5 min. After this initial
heating, the mixture was vortexed for 1 min and returned to
Fig. 1 e FT-IR spectra of PAMAMG0.5, G1.0, G1.5, G2.0, G2.5,
G3.0.
Fig. 2 e FT-IR spectra of MWNTs, COOH-MWNTs, PAMAM-
MWNTs.
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ferred to a bath containing icewater. The powderswere kept at
40 C for 24 h.
2.5.2. The incipient wetness impregnation method (Ⅱ)
A concentrated solution of the CAR in methanol was prepared
and added to PAMAM-MWNTs. Continuous agitation was
applied during the addition of the CAR solution. The products
were dried at 40 C for 24 h.
2.5.3. The solvent method (Ⅲ)
A 50 mg mixture of CAR and PAMAM-MWNTs was prepared
and added to 100 ml methanol. After agitating for several
hours, the solution was filtered and dried at 40 C for 24 h. The
rate of the CAR and PAMAM-MWNTs addition, the agitation
time and the volume of methanol were adjusted to obtain
maximum drug loading.
2.6. In vitro release and solubility of CAR
In order to determine the solubility of the drug, standard
curves were prepared in distilled water and buffer solutions.
The absorbance of the standard solutions prepared in the
concentration range of 4e28 mg/ml was measured at 284 nm
(kmax) using a UV spectrophotometer. In all cases, standard
curves prepared for the determination of the drug concen-
tration in samples, were linear with R2 > 0.999.
In vitro dissolution studies were performed in HCl solution
(pH ¼ 1) and PBS buffer (pH ¼ 6.8). In each dissolution test,
pure CAR and its products containing 10 mg CAR were
weighed and added to 900 ml (under sink conditions) disso-
lutionmedium and stirred at 100 rpm at 37 0.1 C. Then, 5ml
samples were withdrawn at planned times and immediately
passed through amembrane filter (0.22 mm). At each sampling
time, an equal volume of fresh medium was added. The
concentrations of CAR in the filtered solutions weremeasured
by UV spectrophotometry.
To check the solubility of the CAR, excess drug or prepara-
tions was added to a conical flask containing 20 ml distilled
water,HCl solution (pH¼1) andPBSbuffer (pH¼6.8). Eachflask
was tightly corked and placed in a thermostatically controlled
water bath at 37.0 C and agitated for 96 h. After this, the so-
lutions were withdrawn, and passed through a 0.22 mm filter,
diluted with medium and the drug concentration in the final
sample solutions was determined by UV spectrophotometry.
2.7. Physicochemical characterization
2.7.1. Scanning electron microscopy (SEM) observations and
Fourier transform infrared (FT-IR) studies
The morphology was studied by SEM (Supra 35, ZEISS, Ger-
many). The FT-IR spectra were recorded on an FT-IR spec-
trometer (Spectrum 1000, Perkin Elmer, USA). The IR spectra,
in the absorbance mode, were obtained over the spectral
range 400e4000 cm1.
2.7.2. Thermogravimetric (TGA) and difference scanning
calorimetry (DSC) analysis
Thermogravimetric Analysis (TGA) (Shimadzu, Japan) was
performed to determine the actual drug loading. The sampleswere heated to 600 Cwith a heating rate of 10 C/min1 under
a nitrogen purge of 40 ml/min. The drug content was deter-
mined from the weight loss between 200 and 600 C. The
physical state of the CAR in the PAMAM-MWNTs was
analyzed using Differential Scanning Calorimetry (DSC)
(Q1000, TA Instruments, USA). The samples were heated from
30 to 150 C at a rate of 10 C/min1. Indium was used to
calibrate the temperature scale and the enthalpic response.
The samples were analyzed in open aluminum sample pans.
2.7.3. X-ray diffraction (XRD) and X-ray photoelectron
spectroscopy (XPS) studies
XRD is a suitable technique to investigate the physical state of
CAR. XRD patterns of the samples were recorded using an X-
ray diffractometer (X’pert PRO, PANalytical B.V, The
Netherlands) equipped with a CuKa target. The X-rays were
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50 (diffraction angle 2q) at a step size of 0.02 and a scanning
speed of 4/min radiation. The composition of the elements on
the surface of the PAMAM-MWNTs was checked by XPS
(ESCALAB250, Thermo VG, USA).
2.7.4. Surface area and pore size studies
The pore characteristics of the samples were studied by
determining the nitrogen adsorption using a surface area and
pore size analyzer (SA3100, Beckman Coulter, USA) at196 C.
All samples were degassed for 12 h at 40 C before measure-
ment. The pore volume and the specific surface area of the
pores were assessed using the linear region of the t-plot prior
to capillary condensation. The total pore volume and the
external surface area were determined using the linear region
of the t-plot following capillary condensation. The pore size
distributions were computed from the adsorption branches of
the isotherms using the BarretteJoynereHalenda (BJH)
approach.3. Results and discussion
3.1. Preparation of PAMAM-MWNTs
Fig. 1 shows the transmission FT-IR spectra of different gen-
erations of PAMAM. From spectra G0.5, G1.5 and G2.5, the peak
at 1740 cm1 was assigned to C]O. The peaks at 1200 cm1
and 1170 cm1 were due to the stretching vibration of CeOeC,
which suggests the presence of an ester function. The peak at
1330 cm1 was assigned to a tertiary amine. The peaks at
2950 cm1 and 2830 cm1 were due to the stretching vibration
of CH3 and CH2. The peak at 1440 cm
1 was due to the bending
vibration of CH2, while the peak at 1360 cm
1 was due to the
bending vibration of CH3. From spectra G1.0, G2.0 and G3.0, theFig. 3 e SEM photographs of MWNTs (A), PAMAM-MWpeaks at 3363 cm1 and 3281 cm1 were assigned to NH2. The
peaks at 2937 cm1 and 2870 cm1 were due to the stretching
vibration of CH2. The peaks at 1644 cm
1 and 1560 cm1 were
assigned to an amide linkage. The peak at 1470 cm1 was due
to the bending vibration of CH2. The peaks at 1200 cm
1 and
1116 cm1 were due to the stretching vibration of a primary
amine and a tertiary amine. Comparison with the half gen-
eration of PAMAM showed that the peak at 1740 cm1
assigned to C]O had disappeared. This suggested a complete
transformation from a half generation to a whole generation.
These results were consistent with the reports [26,27].
The FT-IR spectra of the native and chemically modified
MWNTs are shown in Fig. 2, where a new infrared vibration
absorption band at 1740 cm1 can be seen, since the carbonyl
and carboxyl groups appear on the surface of the MWNTs
during treatment with the mixed concentrated acids. This
result was consistent with the reports [28]. Because the reac-
tion between the amino groups in PAMAM and the carboxylic
groups in carboxylated MWNTs results in PAMAM-MWNTs
with large numbers of amide, amino, carbonyl and carboxyl
groups on the surface of the hybrid, one can see from the
infrared absorption spectrum in Fig. 2 that the absorption
peaks at 1640 and 1550 cm1 have increased substantially.
These absorption peaks are characteristic of amide I and II
bands that arise from amide groups in PAMAM-MWNTs.
Fig. 3 shows the scanning electron images of MWNTs,
PAMAM-MWNTs, CAR and CAR-PAMAM-MWNTs. The
MWNT diameters were in the range of 10e20 nm and the
length of the MWNTs was a few micrometers. Fig. 3A shows
the images of the commercially obtained MWNTs with a very
smooth surface and the open ends of the MWNTs were
clearly visible. Following functionalization (Fig. 3B), the
PAMAM-MWNTs had more open ends (bright spots on the
image) with a granular surface and linked tubes. This indi-
cated that, after treatment, the PAMAM-MWNTs had reactiveNTs (B), CAR (C) and CAR-PAMAM-MWNTs (D).
Fig. 4 e Schematic illustration of the preparation process.
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motif of this preparation process is suggested in Fig. 4.3.2. The stability of PAMAM-MWNTs
Fig. 5 shows the dispersion stability in water. The pristine
MWNTs did not stably disperse in water as shown in Fig. 5a,
the COOH-MWNTs dispersed better (Fig. 5b), in contrast,
PAMAM-MWNTs showed good stability inwater, exhibiting no
decomposition even after one month (Fig. 5c). Sedimentation
ratio was also used to characterize the stability of the three
carriers. The degree of sedimentation ratio (F) was calculated
according to the following equation: F ¼ H/H0  100%, H
defined as the final height of the deposition, well H0 was the
initial height of the solution. The Fa was 22.9%, Fb was 65.5%, Fc
was 100%. The dispersed solution of PAMAM-MWNTs pos-
sesses excellent stability in water due to the presence ofmany
amino groups on the surface. MWNTs were winding and
agglomerating with each other, this decreased its surfaceFig. 5 e Dispersion stability in water. MWNTs (area. Increasing the dispersion stability of the MWNTs could
increase the contact area between the carrier and the drugs.
So the drugs could disperse on the surface of the carrier faster
and better. This excellent dispersion stability will be very
helpful for drug loading and the dissolution of the drug.
The stability of PAMAM-MWNTs in solutions of different
pH was also studied. After stirring for 5 h in solutions of
different pH, the FT-IR spectra failed to show any new ab-
sorption bands (Fig. 6). This indicated that the conjunction of
PAMAM and MWNTs via amide linkages did undergo hydro-
lysis. So, we can conclude that the PAMAM-MWNTs were
stable in distilled water, HCl solution (pH ¼ 1) and PBS buffer
(pH ¼ 6.8).3.3. Drug-loading procedures for PAMAM-MWNTs
The actual drug loading was determined in two ways: via TGA
and using a one-week release experiment under sink condi-
tions. The actual loadings (wt%) are summarized in Table 1.A), COOH-MWNTs (B), PAMAM-MWNTs (C).
Fig. 6 e FT-IR spectra of PAMAM-MWNTs in different pH
solutions.
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amount of 30% CAR that was impregnated using the fusion
method. The high drug-loading capacity was attributed to the
interior hydrophobic core of the PAMAM, it can encapsulate
hydrophobic drugs, dramatically increasing their water solu-
bility and loading amounts, and the interaction between the
amino groups in the PAMAM structure and the hydroxyl
groups in the CAR also plays an important role. Compared to
the theoretical loadings, the measured loadings were slightly
lower. It’s probably due to the traces of CAR remaining
adsorbed on the glassware.3.4. In vitro release and solubility of CAR
The dissolution results are shown in Fig. 7. The samples made
by the fusion method exhibited a better dissolution than the
samples made by the incipient wetness impregnation
method, while the products obtained using the solvent
method exhibited the slowest drug release. Among the sam-
ples made by the fusion method, the dissolution at 3 h of the
sample with the drug-loading of 30% was 80% in the HCl so-
lution, 45% in the PBS buffer. And the dissolution in 8 h was
about 83% in HCl solution, 72% in PBS buffer. The dissolutionTable 1 e Drug-loading values obtained by TGA and
release experiment under sink conditions.
Sample TGA (%) Sink release (%)
Ⅰ-30% 27.3 27.4
Ⅰ-40% 38.8 39.0
Ⅰ-50% 49.8 47.5
Ⅰ-60% 56.9 57.9
Ⅱ-20% 18.7 18.5
Ⅱ-30% 28.3 27.6
Ⅱ-40% 37.6 38.7
Ⅲ-27% 27.0 27.4of the samples made by the incipient wetness impregnation
method was between 60% and 70% in HCl solution, 55%e60%
in the PBS buffer. The dissolutionmade by the solventmethod
was less than 20% in the two mediums. The dissolution of
commercial CAR capsule was also investigated in Fig. 7, the
dissolution rate was increased than the samples we made by
the different drug-loading method. There maybe two factors:
first, it can be attributed to the formation of CAR-PAMAM-
MWNTs system, there was amino groups in the PAMAM
structure, while the CAR had a hydroxyl group, once the
complex was formed, it would surely hinder the release of the
drug inside the system. Second, PAMAM dendrimers are
highly branched with numerous surface groups and charges,
the interior hydrophobic core of the dendrimer can encapsu-
late hydrophobic compounds, thereby suggesting formation
of an electrostatic interactions between the CAR and the
dendrimer interior. Therefore, the PAMAM-MWNTs possesses
unique structural characteristics and desirable properties for
drug delivery.
Also, the samples made by the same drug-loading method,
different dissolution results were obtained in the two disso-
lution media. It was attribute to the solubility of CAR, which
was depended on the pH, it was increased when the pH of the
medium got lower.
In the presence of PAMAM-MWNTs, it was observed that
the solubility of CAR increased significantly (Table 2). Ⅱ-30%
was the samples, which exhibited the highest solubility
enhancement among the samples made using PAMAM-
MWNTs. So we carried out further investigations of the
physicochemical characterization of Ⅱ-30%.3.5. Physicochemical characterization
The drug-loaded samples were examined to determine
whether a crystalline drug phase could be detected. The X-ray
diffraction pattern of PAMAM-MWNTs, CAR and sample CAR-
PAMAM-MWNTs are shown in (Fig. 8). The diffraction pattern
of pure CAR was highly crystalline in nature as indicated byFig. 7 e Release of the CAR in different pH solutions. Each
data point represents the mean ± S.D of three
determinations.
Table 2 e The solubility of the pure CAR and the
preparations in different mediums.
Sample Solubility
in HCl
(mg/ml)
Solubility in
distilled water
(mg/ml)
Solubility in
PBS (pH ¼ 6.8)
(mg/ml)
Pure CAR 101.42 7.67 24.69
Ⅰ-30% 117.56 8.99 28.36
Ⅰ-40% 124.93 12.02 30.84
Ⅰ-50% 119.82 10.26 31.75
Ⅰ-60% 134.63 10.86 39.46
Ⅱ-20% 128.34 9.78 35.87
Ⅱ-30% 156.37 15.43 42.54
Ⅱ-40% 141.53 12.25 39.91
Ⅲ-27% 109.01 8.00 47.62
Fig. 9 e Nitrogen adsorption desorption isotherms of
PAMAM-MWNTs and CAR-PAMAM-MWNTs.
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10 to 40 indicate the crystalline structure of CAR. The X-ray
diffraction pattern of CAR-PAMAM-MWNTs revealed broad
peaks over the range of 10e40, suggesting that no crystals
were present. These results agree with the DSC results.
In addition, the presence or absence of a crystalline drug
was confirmed byDSC analysis by using the drugmelting peak
in it’s thermograms as an indication that CAR was present in
crystalline form in the sample. And if the drug was in a crys-
talline state, then the amount of drug could be estimated by
themelting point depression using DSC. But if the drug was in
a noncrystalline state, then no melting point depression
would be detected. As an example, the DSC curves for
PAMAM-MWNTs, CAR and sample CAR-PAMAM-MWNTs are
shown in the inset of Fig. 8. The thermogram of crystalline
CAR showed a sharp endothermic peak at 118 C, attributed to
its melting. At the same time, the peak at around 40 C sug-
gests an amorphic state. In the sample CAR-PAMAM-MWNTs,
the endothermic peak of CAR was no longer observed sug-
gesting that it might be loaded by MWNTs in molecular form.Fig. 8 e XRD pattern of CAR, PAMAM-MWNTs and CAR-
PAMAM-MWNTs. The inset shows the DSC thermograms
of CAR, PAMAM-MWNTs and CAR-PAMAM-MWNTs.The nitrogen adsorption/desorption isotherms of the pre-
pared PAMAM-MWNTs samples were typical type Ⅳ iso-
therms according to the IUPAC classification, characteristic of
mesoporous materials. As an example, the nitrogen adsorp-
tion/desorption isotherms of PAMAM-MWNTs and sample
CAR-PAMAM-MWNTs are shown in Fig. 9. The isotherm of
PAMAM-MWNTs featured hysteresis loops with sharp
adsorption and desorption branches. The result of the nitro-
gen adsorption investigation is shown in Table 3. From the
data obtained, we can see that there is a clearly reduced pore
volume and specific surface area after drug-loading. The pore
size distribution results suggest that the preparations had a
bimodal pore size distribution, with an uneven distribution
inside the nanotube. This might be due to rapid solvent
evaporation. Before the drug had spread to the central carbon
nanotubes, the solvent evaporation would be complete,
resulting in less distribution in the center compared with the
distribution around the nozzle.
SBET: BET surface area. Vt: Total pore volume. WBJH: Pore
diameter was calculated by using BJH model.
The XPS spectrum of a CAR-PAMAM-MWNTs sample and,
for comparison that of PAMAM-MWNTs, are both presented in
Fig. 10. The amount of carbon, nitrogen and oxygen in the
surface layer is shown in Table. 4. PAMAM G3.0 contained
23.55% nitrogen, and CAR contained 6.90% nitrogen. CAR-
PAMAM-MWNTs had more nitrogen than the PAMAM-
MWNTs. This was because some of the drug was present on
the surface of the carrier. This suggests that PAMAM-MWNTs
acted as a porous absorbent to entrap CAR within an MWNT
mesh or MWNT bundle. In addition, there was a clear shift inTable 3eNitrogen adsorption results of PAMAM-MWNTs
and Ⅱ-30%.
Sample SBET (m
2/g) Vt (cm
3/g) WBJH (nm)
PAMAM-MWNTs 187 0.56 14.0
Ⅱ-30% 89 0.42 7.6
Fig. 10 e XPS spectrum of PAMAM-MWNTs and CAR-
PAMAM-MWNTs.
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399.91 to 396.42) indicating a chemical shift due to fictional-
ization of the MWNTs.
Fig. 3D shows the SEM image of sample CAR-PAMAM-
MWNTs. No crystalline structure was present. This sup-
ported the DSC and XPS results. Three methods of interaction
between MWNTs and pharmaceutically active components
are possible during drug delivery. The first method of inter-
action is as a porous absorbent to entrap active components
within an MWNT mesh or MWNT bundle. The second is
through functional attachment of the compound to the exte-
rior walls of the MWNTs. The third approach involves the use
of MWNT channels as nanocatheters. This was consistent
with the XPS results.4. Conclusion
PAMAM-MWNTs were synthesized as a carrier to load CAR.
Three methods (the fusion method, the incipient wetness
impregnation method, and the solvent method) were used to
load our model drug. The dissolution results showed that the
samples made by the fusion method exhibited a better
dissolution than the samples made by the incipient wetness
impregnation method. Also, the products obtained using the
solvent method exhibited the slowest drug release. However,
all the samples made using PAMAM-MWNTs increased theTable 4 e The element contents on the surface of the
PAMAM-MWNTs and Ⅱ-30%.
Element Content
PAMAM-Mwnts Ⅱ-30%
C 90.6 82.0
O 4.8 11.4
N 4.6 6.6solubility of CAR significantly, especially the Ⅱ-30%. The
physicochemical characterization allowed us to see the dis-
tribution of CAR inside and outside the PAMAM-MWNTs from
themolecular form. The new drug delivery systemmay offer a
potential advantage on poorly water-soluble drugs for
enhanced dissolution and drug-loading capacity.
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